Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Allakos Announced The Publication Of New Scientific Results In Allergy. The Preclinical Research Found That AK006 (Agonist Siglec-6 Antibody) Impacts Mast Cell Function By Interacting With Multiple Activating Receptors And Key Signaling Molecules

Author: Benzinga Newsdesk | February 12, 2024 08:32am

Posted In: ALLK

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist